agilon health (AGL) Stock Forecast, Price & News

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for agilon health in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AGL shares.
View AGL analyst ratings or view top-rated stocks.

7 analysts have issued 1 year price objectives for agilon health's stock. Their AGL share price forecasts range from $22.50 to $32.00. On average, they expect the company's share price to reach $27.39 in the next year. This suggests a possible upside of 45.6% from the stock's current price.
View analysts price targets for AGL or view top-rated stocks among Wall Street analysts.

agilon health's stock was trading at $16.14 at the start of the year. Since then, AGL shares have increased by 16.5% and is now trading at $18.81.
View the best growth stocks for 2023 here.

agilon health saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 40,190,000 shares, an increase of 10.5% from the August 15th total of 36,380,000 shares. Based on an average trading volume of 2,640,000 shares, the short-interest ratio is currently 15.2 days. Approximately 13.3% of the company's shares are sold short.
View agilon health's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our AGL earnings forecast.

agilon health, inc. (NYSE:AGL) released its earnings results on Thursday, August, 3rd. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.03. The business had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.11 billion. agilon health had a negative trailing twelve-month return on equity of 8.57% and a negative net margin of 2.39%.

ETFs with the largest weight of agilon health (NYSE:AGL) stock in their portfolio include Fidelity Disruptive Medicine ETF (FMED), SPDR S&P Health Care Services ETF (XHS), iShares U.S. Healthcare Providers ETF (IHF), Renaissance IPO ETF (IPO), Fidelity Growth Opportunities ETF (FGRO) and Global X Aging Population ETF (AGNG).RiverNorth Patriot ETF (FLDZ) and

agilon health issued an update on its third quarter 2023 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.13 billion-$1.14 billion, compared to the consensus revenue estimate of $1.10 billion.

(AGL) raised $1 billion in an IPO on Thursday, April 15th 2021. The company issued 46,600,000 shares at $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities acted as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers.

agilon health trades on the New York Stock Exchange (NYSE) under the ticker symbol "AGL."

agilon health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Clayton Dubilier & Rice LLC (24.11%), Capital World Investors (12.66%), Capital Research Global Investors (3.75%), BlackRock Inc. (3.19%), Capital International Investors (2.32%) and Rock Springs Capital Management LP (2.04%). Insiders that own company stock include Benjamin Kornitzer, Benjamin Shaker, Cd&R Investment Associates Ix,, Clay Richards, Glenn Sobotka, Joan Danieley, John William Wulf, Michael L Smith, Steven Sell, Theodore Halkias, Timothy Gertsch and Veeral Desai.
View institutional ownership trends.

Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AGL stock can currently be purchased for approximately $18.81.

agilon health (NYSE:AGL) has a market capitalization of $7.63 billion and generates $2.71 billion in revenue each year. The company earns $-106,550,000.00 in net income (profit) each year or ($0.21) on an earnings per share basis.

The company employs 747 workers across the globe.

The official website for the company is agilonhealth.com. The company can be reached via phone at 562-256-3800 or via email at investor.relations@agilonhealth.com.